Literature DB >> 8057256

Mechanism of force inhibition by 2,3-butanedione monoxime in rat cardiac muscle: roles of [Ca2+]i and cross-bridge kinetics.

P H Backx1, W D Gao, M D Azan-Backx, E Marban.   

Abstract

1. We investigated the mechanism of force inhibition by 2,3-butanedione monoxime (BDM) on rat cardiac trabeculae. [Ca2+]i was measured by iontophoretic injection of fura-2 salt. Isometric force was recorded at an end-systolic sarcomere length of 2.1-2.2 microns. 2. With an external [Ca2+] of 1 mM, peak twitch force was monotonically reduced with increasing [BMD]; at 5 and 20 mM [BDM], force was 35 and 1% of the control force. In contrast, the mean peak [Ca2+]i during transients was only reduced at [BDM] > or = 10 mM. 3. The duration of the twitch was dramatically reduced by BDM in a dose-dependent fashion with no significant change in the time course of the underlying Ca2+ transients. The abbreviation of twitch force duration was much greater than expected for the observed reduction in peak force by this agent. 4. The mechanism of the inhibition of force by BDM was explored by examining the relationship between twitch force and Ca2+ transients at various values of external [Ca2+]. In the presence of BDM, the steepness of the relationship between peak force and peak [Ca2+]i was reduced compared to control conditions. As a result, significant elevation in the [Ca2+]i transient was unable to reverse the reduction in force observed in the presence of BDM. 5. The direct inhibitory effects of BDM on the contractile system were examined using ryanodine tetani in intact trabeculae to measure the steady-state force-[Ca2+]i relationship. In contrast to the effects on twitch force at 5 mM BDM, maximal force was only reduced to 71% of control. Furthermore, the [Ca2+]i required for half-maximal activation (Ca50) was increased while the Hill coefficient was reduced slightly by BDM. 6. BDM dramatically slowed the rate of rise of tetanic force. At maximal activation, the time required to reach 90% maximal force was prolonged by a factor of 3-8 in the presence of 5 mM BDM. This suggests that the observed reduction in twitch force and steady-state force may result from slowed kinetics of cross-bridge attachment, consistent with recent biochemical studies. 7. The contribution of altered cross-bridge kinetics to the effects of BDM was investigated using a co-operative cross-bridge model of the contractile system. Changing the rate constants for cross-bridge attachment in the model to mimic the reported biochemical effects of BDM reproduced the observed effects of BDM.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057256      PMCID: PMC1160462          DOI: 10.1113/jphysiol.1994.sp020149

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase.

Authors:  M J Holroyde; S P Robertson; J D Johnson; R J Solaro; J D Potter
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

2.  Inotropic actions of diacetyl monoxime in cat ventricular muscle.

Authors:  J R Wiggins; J Reiser; D F Fitzpatrick; J L Bergey
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

3.  Quantitation of intracellular free calcium in single adult cardiomyocytes by fura-2 fluorescence microscopy: calibration of fura-2 ratios.

Authors:  Q Li; R A Altschuld; B T Stokes
Journal:  Biochem Biophys Res Commun       Date:  1987-08-31       Impact factor: 3.575

4.  The effects of 2,3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles.

Authors:  E M Blanchard; G L Smith; D G Allen; N R Alpert
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

5.  Effects of 2,3-butanedione monoxime on contraction of frog skeletal muscles: an X-ray diffraction study.

Authors:  N Yagi; S Takemori; M Watanabe; K Horiuti; Y Amemiya
Journal:  J Muscle Res Cell Motil       Date:  1992-04       Impact factor: 2.698

6.  Fluorescent properties of rat cardiac trabeculae microinjected with fura-2 salt.

Authors:  P H Backx; H E Ter Keurs
Journal:  Am J Physiol       Date:  1993-04

7.  Comparison between the effects of 2-3 butanedione monoxime (BDM) and calcium chloride on myocardial oxygen consumption.

Authors:  P P de Tombe; D Burkhoff; W C Hunter
Journal:  J Mol Cell Cardiol       Date:  1992-08       Impact factor: 5.000

8.  Mechanism of action of 2, 3-butanedione 2-monoxime on contraction of frog skeletal muscle fibres.

Authors:  K Horiuti; H Higuchi; Y Umazume; M Konishi; O Okazaki; S Kurihara
Journal:  J Muscle Res Cell Motil       Date:  1988-04       Impact factor: 2.698

9.  Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.

Authors:  H Higuchi; S Takemori
Journal:  J Biochem       Date:  1989-04       Impact factor: 3.387

10.  Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes.

Authors:  B Siegmund; T Klietz; P Schwartz; H M Piper
Journal:  Am J Physiol       Date:  1991-02
View more
  28 in total

1.  A common mechanism for concurrent changes of diastolic muscle length and systolic function in intact hearts.

Authors:  L Lu; Y Xu; P Zhu; C Greyson; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-04       Impact factor: 4.733

2.  Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing.

Authors:  John P Konhilas; Thomas C Irving; Beata M Wolska; Eias E Jweied; Anne F Martin; R John Solaro; Pieter P de Tombe
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

3.  Length-dependent activation in three striated muscle types of the rat.

Authors:  John P Konhilas; Thomas C Irving; Pieter P de Tombe
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

4.  Regional increase in extracellular potassium can be arrhythmogenic due to nonuniform muscle contraction in rat ventricular muscle.

Authors:  Masahito Miura; Taiki Hattori; Naomi Murai; Tsuyoshi Nagano; Taichi Nishio; Penelope A Boyden; Chiyohiko Shindoh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

5.  Mitochondrial networks in cardiac myocytes reveal dynamic coupling behavior.

Authors:  Felix T Kurz; Thomas Derungs; Miguel A Aon; Brian O'Rourke; Antonis A Armoundas
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

6.  Culture and adenoviral infection of sinoatrial node myocytes from adult mice.

Authors:  Joshua R St Clair; Emily J Sharpe; Catherine Proenza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-22       Impact factor: 4.733

7.  Blebbistatin: use as inhibitor of muscle contraction.

Authors:  Gerrie P Farman; Kittipong Tachampa; Ryan Mateja; Olivier Cazorla; Alain Lacampagne; Pieter P de Tombe
Journal:  Pflugers Arch       Date:  2007-11-10       Impact factor: 3.657

8.  Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Authors:  John Terrovitis; Riikka Lautamäki; Michael Bonios; James Fox; James M Engles; Jianhua Yu; Michelle K Leppo; Martin G Pomper; Richard L Wahl; Jurgen Seidel; Benjamin M Tsui; Frank M Bengel; M Roselle Abraham; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

9.  Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts.

Authors:  Martin K Slodzinski; Miguel A Aon; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2008-08-07       Impact factor: 5.000

10.  Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium.

Authors:  Xiaoxu Shen; Zhen Tan; Xin Zhong; Ye Tian; Xian Wang; Bo Yu; Genaro Ramirez-Correa; Anne Murphy; Kathleen Gabrielson; Nazareno Paolocci; Wei Dong Gao
Journal:  J Appl Physiol (1985)       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.